These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33069858)

  • 41. Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care.
    Rajasingham R; Meya DB; Boulware DR
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):e85-91. PubMed ID: 22410867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand.
    Harris JR; Lindsley MD; Henchaichon S; Poonwan N; Naorat S; Prapasiri P; Chantra S; Ruamcharoen F; Chang LS; Chittaganpitch M; Mehta N; Peruski L; Maloney SA; Park BJ; Baggett HC
    Clin Infect Dis; 2012 Mar; 54(5):e43-50. PubMed ID: 22198791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevalence and factors associated with cryptococcal antigenemia in HIV-infected patients in Cotonou/Benin].
    Ogouyèmi-Hounto A; Zannou DM; Ayihounton G; Ahouada C; Azon-Kouanou A; Acakpo J; Sissinto Savi de Tove Y; Kinde Gazard D
    J Mycol Med; 2016 Dec; 26(4):391-397. PubMed ID: 27641486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review.
    Derbie A; Mekonnen D; Woldeamanuel Y; Abebe T
    BMC Infect Dis; 2020 Jun; 20(1):407. PubMed ID: 32527231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility and Acceptability of Cryptococcal Antigen Screening and Prevalence of Cryptocococcemia in Patients Attending a Resource-Limited HIV/AIDS Clinic in Malawi.
    Chipungu C; Veltman JA; Jansen P; Chiliko P; Lossa C; Namarika D; Benner B; Hoffman RM; Bristow CC; Klausner JD
    J Int Assoc Provid AIDS Care; 2015; 14(5):387-90. PubMed ID: 26139095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center.
    Vidal JE; Toniolo C; Paulino A; Colombo AL; Martins MDA; Meira CDS; Azevedo RGS; Pereira-Chioccola VL; Gomes HR; Lazera MDS; Oliveira ACP; Boulware DR
    Rev Inst Med Trop Sao Paulo; 2018; 60():e1. PubMed ID: 29451598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of Cryptococcal Antigenemia and associated factors among HIV/AIDS patients on second-line antiretroviral therapy at two hospitals in Western Oromia, Ethiopia.
    Geda N; Beyene T; Dabsu R; Mengist HM
    PLoS One; 2019; 14(12):e0225691. PubMed ID: 31805085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
    Rajasingham R; Smith RM; Park BJ; Jarvis JN; Govender NP; Chiller TM; Denning DW; Loyse A; Boulware DR
    Lancet Infect Dis; 2017 Aug; 17(8):873-881. PubMed ID: 28483415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.
    Coetzee LM; Cassim N; Sriruttan C; Mhlanga M; Govender NP; Glencross DK
    PLoS One; 2018; 13(6):e0198993. PubMed ID: 29894509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study.
    Wajanga BM; Kalluvya S; Downs JA; Johnson WD; Fitzgerald DW; Peck RN
    J Int AIDS Soc; 2011 Oct; 14():48. PubMed ID: 21988905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts.
    Montgomery MP; Nakasujja N; Morawski BM; Rajasingham R; Rhein J; Nalintya E; Williams DA; Huppler Hullsiek K; Kiragga A; Rolfes MA; Donahue Carlson R; Bahr NC; Birkenkamp KE; Manabe YC; Bohjanen PR; Kaplan JE; Kambugu A; Meya DB; Boulware DR;
    BMC Neurol; 2017 Jun; 17(1):110. PubMed ID: 28606065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the initial 12 months of a routine cryptococcal antigen screening program in reduction of HIV-associated cryptococcal meningitis in Uganda.
    Enock K; Julius K; Griffith BC; Abila DB; Rutakingirwa MK; Kasibante J; Kandole KT; Kwizera R; Semeere A; Meya DB
    BMC Health Serv Res; 2022 Mar; 22(1):301. PubMed ID: 35246128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preventing deaths from cryptococcal meningitis: from bench to bedside.
    Roy M; Chiller T
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of Asymptomatic Cryptococcal Antigenemia and Association with Follow-up Risk of Cryptococcal Meningitis and Mortality among HIV Infected Patients in North West India: A Prospective Cohort Study.
    Bhati R; Pramendra S; Sejoo B; Kumar D; Bohra GK; Meena DS; Verma D; Midha NK
    Curr HIV Res; 2021; 19(1):35-39. PubMed ID: 32860359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparative evaluation of three methods for the rapid diagnosis of cryptococcal meningitis (CM) among HIV-infected patients in Northern Malawi.
    Chisale MR; Salema D; Sinyiza F; Mkwaila J; Kamudumuli P; Lee HY
    Malawi Med J; 2020 Mar; 32(1):3-7. PubMed ID: 32733652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda.
    Ramachandran A; Manabe Y; Rajasingham R; Shah M
    BMC Infect Dis; 2017 Mar; 17(1):225. PubMed ID: 28335769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic.
    Reepalu A; Balcha TT; Yitbarek T; Jarso G; Sturegård E; Björkman P
    BMC Res Notes; 2015 Nov; 8():702. PubMed ID: 26597840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of Cryptococcus antigen in human immunodeficiency virus-positive Turkish patients by using the Dynamiker
    Karaman E; Ilkit M; Kuşçu F
    Mycoses; 2019 Oct; 62(10):961-968. PubMed ID: 31344286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cryptococcal antigenemia in people living with HIV and AIDS.
    Ahuja J; Soneja M; Wig N; Biswas A; Xess I; Singh G; Vibha D; Nischal N
    Int J STD AIDS; 2023 Feb; 34(2):130-136. PubMed ID: 36426734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased mortality among HIV infected patients with cryptococcal antigenemia in Guinea-Bissau.
    Thomsen D; Hviid CJ; Hønge BL; Medina C; Té DDS; Correira FG; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Jespersen S
    Pan Afr Med J; 2018; 29():18. PubMed ID: 29662603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.